Published in Prog Urol on February 01, 2007
Environmental non-occupational risk factors associated with bladder cancer. Actas Urol Esp (2013) 0.78
Prostate cancer as a first and second cancer: effect of family history. Br J Cancer (2009) 0.75
Collecting duct renal cell carcinoma: a matched analysis of 41 cases. Eur Urol (2007) 2.30
Multi-institutional validation of a new renal cancer-specific survival nomogram. J Clin Oncol (2007) 2.09
[Current place of chemotherapy in the treatment of hormone-refractory metastatic prostate cancer]. Prog Urol (2005) 2.01
Accuracy and clinical role of fine needle percutaneous biopsy with computerized tomography guidance of small (less than 4.0 cm) renal masses. J Urol (2004) 1.63
Renal cell carcinoma in adults 40 years old or less: young age is an independent prognostic factor for cancer-specific survival. Eur Urol (2006) 1.36
High-intensity focused ultrasound in prostate cancer; a systematic literature review of the French Association of Urology. BJU Int (2008) 1.34
Relationship between age at diagnosis and clinicopathologic features of renal cell carcinoma. Eur Urol (2006) 1.27
Cold ischemia time in renal transplantation is reduced by a timesheet in a French transplant center. Transplantation (2007) 1.21
Immunocyt test improves the diagnostic accuracy of urinary cytology: results of a French multicenter study. J Urol (2003) 1.12
Attempted isolation of Nanobacterium sp. microorganisms from upper urinary tract stones. J Clin Microbiol (2003) 1.11
Age at diagnosis is a determinant factor of renal cell carcinoma-specific survival in patients treated with nephrectomy. Can Urol Assoc J (2008) 1.03
Conditional survival predictions after nephrectomy for renal cell carcinoma. J Urol (2009) 1.02
Follow-up of renal oncocytoma diagnosed by percutaneous tumor biopsy. Urology (2005) 1.01
Unclassified renal cell carcinoma: an analysis of 85 cases. BJU Int (2007) 0.98
Microarray gene expression profiling and analysis of bladder cancer supports the sub-classification of T1 tumours into T1a and T1b stages. BJU Int (2013) 0.97
Prostate cancer in renal transplant recipients. Nephrol Dial Transplant (2008) 0.95
Neural cell adhesion molecule expression in renal cell carcinomas: relation to metastatic behavior. Hum Pathol (2003) 0.94
Follow-up after surgical treatment of bladder cancer: a critical analysis of the literature. Eur Urol (2012) 0.92
De novo renal cell carcinoma of native kidney in renal transplant recipients. Cancer (2005) 0.92
Can renal mass biopsy assessment of tumor grade be safely substituted for by a predictive model? J Urol (2009) 0.89
Does management of erectile dysfunction after radical prostatectomy meet patients' expectations? Results of a national survey (REPAIR) by the French Urological Association. J Sex Med (2008) 0.89
Seminal vesicle invasion: what is the best adjuvant treatment after radical prostatectomy? BJU Int (2011) 0.89
Diagnosis and treatment of prostate cancers in renal-transplant recipients. Transplantation (2003) 0.86
[Percutaneous nephrolithotomy (PCNL) in subjects over the age of 70: a multicentre retrospective study of 210 cases]. Prog Urol (2004) 0.85
Expression and role of adrenomedullin in renal tumors and value of its mRNA levels as prognostic factor in clear-cell renal carcinoma. Int J Cancer (2009) 0.85
Transurethral ureterorenolithotripsy using new automated irrigation/suction system controlling pressure and flow compared with standard irrigation: a randomized pilot study. J Endourol (2003) 0.84
[Urinary stones in subjects over the age of sixty]. Prog Urol (2004) 0.84
Prognostic variables to predict cancer-related death in incidental renal tumours. BJU Int (2008) 0.84
Stage-specific effect of nodal metastases on survival in patients with non-metastatic renal cell carcinoma. BJU Int (2008) 0.83
[Tamsulosin with or without Serenoa repens in benign prostatic hyperplasia: the OCOS trial]. Prog Urol (2002) 0.81
Laparoscopic living-donor nephrectomy: is it really better? Eur Urol (2010) 0.79
Risk stratification of metastatic recurrence in invasive upper urinary tract carcinoma after radical nephroureterectomy without lymphadenectomy. World J Urol (2013) 0.79
[Complications of "Acucise" balloon endopyelotomy]. Prog Urol (2003) 0.79
Complete pathological response after sequential therapy with sunitinib and radiotherapy for metastatic clear cell renal carcinoma. Anticancer Res (2012) 0.79
[Intravesical BCG instillations for the treatment of superficial bladder tumours in renal transplant recipients]. Prog Urol (2006) 0.78
[Urological problems encountered during pregnancy]. Prog Urol (2005) 0.78
[Management of positive margins after total prostatectomy for localized prostate cancer]. Prog Urol (2006) 0.78
[Prostate-sparing cystectomy: long-term functional and oncological results in a series of 25 cases]. Prog Urol (2004) 0.77
Editorial comment on: Cytological punctures in diagnosis of renal tumours: a study on accuracy and reproducibility. Eur Urol (2008) 0.76
Editorial comment on: Ultrasound-guided biopsy of homogenous solid renal masses. Eur Urol (2007) 0.75
[High risk prostate cancer results of one year RT-HT]. Prog Urol (2005) 0.75
Uretero-fallopian fistula after gynecological surgery for endometriosis: a case report. J Minim Invasive Gynecol (2008) 0.75
[MTOR inhibitors: from transplantation to oncology. AFU 2006 Transplantation Committee Review of the literature]. Prog Urol (2007) 0.75
[Reduction of the renal transplantation cold ischaemia time by the use of a timesheet]. Prog Urol (2005) 0.75
[De novo cancer in a kidney transplant]. Prog Urol (2004) 0.75
[Without delay we should invent urological surgery for tomorrow]. Presse Med (2005) 0.75
[Inferior calyx stone and flexible ureterorenoscopy to mobilize the stone before fragmentation]. Prog Urol (2006) 0.75
[Tubulopapillary tumours of the kidney: prognostic value and therapeutic implications of the distinction between type 1 and type 2 based on a series of 58 cases]. Prog Urol (2005) 0.75
[Renal transplantation and tumour transmission]. Prog Urol (2007) 0.75
[The prostate, symbol of male vulnerability: an AFU-IPSOS quality survey]. Prog Urol (2006) 0.75
[Renal oncocytoma associated with renal cell carcinoma]. Prog Urol (2005) 0.75
[Flexible ureteroscopy and holmium-Yag laser: material and technique]. Prog Urol (2006) 0.75
[Outcome of oncocytomas diagnosed by percutaneous renal biopsy]. Prog Urol (2006) 0.75
[Treatment of precalyceal stones of Cacchi-Ricci disease by flexible ureterorenoscopy and Holmium-YAG laser]. Prog Urol (2006) 0.75
[Treatment of inferior caliceal stones by flexible ureteroscopy]. Prog Urol (2005) 0.75
[Limited prognostic value of surgical biopsy before transplantation of good quality renal transplants]. Prog Urol (2004) 0.75
[Renal oncocytoma]. Prog Urol (2006) 0.75
[Prostate cancer screening]. Prog Urol (2003) 0.75
[ABO-incompatible renal transplantation]. Prog Urol (2006) 0.75
[We must screen prostate cancer in the general population]. Presse Med (2007) 0.75
[Flexible ureteroscopy in upper urinary tract diseases]. Prog Urol (2003) 0.75
[Study of urothelial bladder tumours in renal transplant recipients]. Prog Urol (2006) 0.75
[Endoscopic management of urothelial tumours of the upper urinary tract]. Prog Urol (2006) 0.75
[The prostate: how to treat this symbol of male vulnerability? An Association Française d'Urologie (AFU)-IPSOS qualitative survey]. Prog Urol (2007) 0.75
[Renal tumours]. Rev Prat (2007) 0.75
[National prospective survey on the surgical quality of renal transplants in France. Study conducted by the Association Française d'Urologie Transplantation Committee]. Prog Urol (2007) 0.75
[Prostate cancer at high risk of recurrence: results of 12 months of radiotherapy-hormone therapy]. Prog Urol (2005) 0.75
[Contribution of laparoscopy to vesico-ureteral reimplantation on vesico-psoas]. Prog Urol (2003) 0.75